MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, MYGN made $205,700K in revenue. -$27,400K in net income. Net profit margin of -13.32%.

Income Overview

Revenue
$205,700K
Net Income
-$27,400K
Net Profit Margin
-13.32%
EPS
-$0.29
Unit: Thousand (K) dollars
Revenue Breakdown
    • US
    • Revenue From Contract With Custo...
    • Revenue From Contract With Custo...
    • Others
Revenue Breakdown
    • US
    • Non Us

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Revenue
205,700 213,100 195,900 206,400
Cost of revenue
61,900 61,300 61,700 62,150
Gross profit
143,800 151,800 134,200 146,350
Research and development expense
28,200 25,600 27,500 28,900
Sales and marketing expense
71,000 71,900 69,200 71,025
Legal settlements
----5,325
General and administrative expense
67,900 66,800 66,500 68,975
Goodwill and long-lived asset impairment charges
0 316,700 -11,025
Total operating expenses
167,100 481,000 163,200 174,600
Operating loss
-23,300 -329,200 -29,000 -33,500
Interest income
500 200 300 450
Interest expense
3,800 1,500 800 600
Other
400 -100 100 1,100
Total other income (expense), net
-2,900 -1,400 -400 950
Loss before income tax
-26,200 -330,600 -29,400 -32,550
Income tax expense (benefit)
1,200 -100 -29,300 1,700
Net loss
-27,400 -330,500 -100 -34,250
Basic (dollars per share)
-0.29 -3.57 0 -0.38
Basic (shares)
93,100,000 92,500,000 91,400,000 -45,450,000
Diluted (dollars per share)
-0.29 -3.57 0 -0.38
Diluted (shares)
93,100,000 92,500,000 91,400,000 -45,450,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Revenue From ContractWith Customer...$38,700K Revenue From ContractWith Customer...$44,500K Non Us$2,800K US$26,700K Non Us$11,200K US$81,800K Net loss-$27,400K Pharmacogenomics$38,700K Prenatal Testing$44,500K Tumor Profiling$29,500K Hereditary Cancer Testing$93,000K Income tax expense(benefit)$1,200K Loss before incometax-$26,200K Revenue$205,700K Total other income(expense), net-$2,900K Operating loss-$23,300K Other$400K Interest income$500K Gross profit$143,800K Cost of revenue$61,900K Interest expense$3,800K Total operatingexpenses$167,100K General andadministrative expense$67,900K Sales and marketingexpense$71,000K Research and developmentexpense$28,200K

MYRIAD GENETICS INC (MYGN)

MYRIAD GENETICS INC (MYGN)